Table 1– The four parts of the tuberculosis (TB)–HIV co-infection survey sent to European Centre for Disease Prevention and Control TB contact points in European Union/European Economic Area countries
1Information on the national TB surveillance systemThis section focussed on whether TB was notifiable in the country, the geographic coverage of the TB surveillance system, population groups that were under-reported and the information collected for a reported case
2Practices and possibilities of collecting HIV status among TB patientsStarting with the question of whether information on co-infection status was available for individual TB cases reported to the national surveillance system, the questions assessed how this information was obtained, the completeness of this information, and advantages and disadvantages of the way the information was obtained
3Guidance on, barriers to and drivers of TB–HIV co-infectionThis section included questions on resources for TB–HIV co-infection surveillance in addition to those for TB surveillance separately, the availability of national guidelines for diagnosis and treatment of TB and TB–HIV, testing/screening practices and estimates for the proportion of TB patients tested for HIV, collaborative TB–HIV projects, and perceived support and barriers
4The burden of TB–HIV co-infectionAssessing the definition of co-infection used for reporting purposes, the burden in terms of total number and proportion of TB cases co-infected with HIV, as well as the number of co-infected cases by sex, <15 and >15 yrs of age, with drug resistance, under DOT, who completed treatment, and who died
  • DOT: directly observed therapy.